Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multi-centre, Post Marketing Surveillance to Observe the Safety and Effectiveness of ARNUITY Administered in Patients With Asthma in Usual Practice

NCT03595930 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT03595930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03595930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multi-centre, Post Marketing Surveillance to Observe the Safety and Effectiveness of ARNUITY Administered in Patients With Asthma in Usual Practice
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
September 21, 2018
Completion date
July 22, 2020
Enrollment
668 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma